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Introduction: Postural tachycardia syndrome (POTS) is a suspected dysautonomia
with symptoms of orthostatic intolerance and abnormally increased heart rate while
standing. We aimed to study cardiac autonomic nervous system functioning in head-
up tilt (HUT) in adolescents with POTS to find out if parasympathetic tone is attenuated
in the upright position.
Methods: We compared characteristics of a group of 25 (females 14/25; 56%)
adolescents with POTS and 12 (females 4/12; 34%) without POTS aged 9–17 years.
We compared heart rate variability with high- and low-frequency oscillations, and their
temporal changes in HUT.
Results: The high-frequency oscillations, i.e., HF, attenuated in both groups during HUT
(p < 0.05), but the attenuation was bigger in POTS (p = 0.04). In the beginning of HUT,
low-frequency oscillations, i.e., LF, increased more in POTS (p = 0.01), but in the end of
HUT, an attenuation in LF was seen in the POTS group (p< 0.05), but not in the subjects
without POTS. There were no associations of previous infections or vaccinations with
POTS. Subjects with POTS were sleepier and their overall quality of life was very low.
Conclusion: The results imply to an impaired autonomic regulation while standing
in POTS, presenting as a lower HF and higher LF in the beginning of HUT and an
attenuated LF in the prolonged standing position.
Keywords: postural tachycardia syndrome, adolescent, head-up tilt test, autonomic nervous system, heart rate
variability
INTRODUCTION
Postural tachycardia syndrome (POTS) is a type of functional dysautonomia characterized by
symptoms of orthostatic intolerance accompanied with abnormally increased heart rate (HR)
while standing (Sheldon et al., 2015). Diagnostic criteria for POTS are symptoms of orthostatic
intolerance lasting ≥ 6 months together with an increase in HR of ≥ 30 beats per minute
Abbreviations: ADHD, attention-deficit hyperactivity disorder; ANS, autonomic nervous system; BMI, body mass index; BP,
blood pressure; DBP, diastolic blood pressure; EBV, Epstein–Barr virus; ESS, Epworth Sleepiness Scale; HF, high-frequency
components of the heart rate variability spectra; HHV6, human herpesvirus 6; HPV, human papillomavirus; HR, heart
rate; HRV, heart rate variability; HUT, head-up tilt; LF, low-frequency components of the heart rate variability spectra;
LF/HF, LF/HF ratio; MAP, mean arterial pressure; NIP, Finnish National Immunization Program; POTS, postural tachycardia
syndrome; RDS, Rimon’s Brief Depression Scale; SBP, systolic blood pressure; WHO-5, World Health Organization–Five
Well-Being Index.
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(bpm) for at least 30 s when moving from a recumbent
to a standing position but without simultaneous orthostatic
hypotension [>20 mmHg drop in systolic blood pressure (SBP)],
and other causative conditions or medications must be ruled out
(Sheldon et al., 2015). For subjects under 19 years old, an increase
of HR ≥ 40 bpm and symptoms of orthostatic intolerance are
needed (Sheldon et al., 2015).
A prevalence of 0.2% with a 4:1–5:1 female/male ratio has
been described for POTS (Kimpinski et al., 2012; Sheldon et al.,
2015). The number of POTS diagnoses is increasing, presumably
as a result of better disease recognition (Skufca et al., 2017;
Brinth et al., 2018).
In addition to symptoms of orthostatic intolerance, POTS
patients often suffer from chronic pain, gastrointestinal
symptoms, fatigue, and sleep disturbance, and symptoms worsen
with upright position (Sheldon et al., 2015). Patients with
POTS have only mild symptoms of general autonomic failure
(Kimpinski et al., 2012), and orthostatic intolerance is the most
severe autonomic symptom.
The cause of POTS has not yet been established (Benarroch,
2012), though many possible disease mechanisms including
autonomic denervation (Kimpinski et al., 2012; Haensch
et al., 2014), autonomic autoimmunity (Ruzieh et al., 2017),
hypovolemia (Benarroch, 2012; Kimpinski et al., 2012),
hyperadrenergic stimulation (Kimpinski et al., 2012), and
deconditioning have been proposed (Benarroch, 2012; Fu and
Levine, 2015). The entity of symptoms in POTS patients is likely
caused by a combination of these factors.
Heart rate variability (HRV) is an ECG-based method to assess
cardiac autonomic nervous system (ANS) (Camm et al., 1996).
HR has a constant beat-to-beat temporal variation mediated
by autonomic sympathetic and parasympathetic nervous system
influences on the sinus node. HRV is a good method to
estimate the parasympathetic nervous system (high-frequency
oscillations, HF), but the method is not so well validated in
measuring the sympathetic nervous system, and low-frequency
oscillations, LF, consist of both parasympathetic and sympathetic
influences on the sinus node (Camm et al., 1996). LF/HF depicts
the ratio of LF and HF (Camm et al., 1996).
In recent years, numerous studies of POTS patients’ head-
up tilt (HUT) test describing HRV have been published (Furlan
et al., 1998; Corkal et al., 2014; Baker et al., 2018a; Swai et al.,
2019), but only a few with adolescent subjects (Stewart, 2000;
Swai et al., 2019). In one study, a different definition of POTS was
used, in other words, a milder heart rate increase was accepted
(Yoshida et al., 2014). HRV parameters (HF and LF) during
HUT test correlated with autonomic dysfunction in POTS and
in other autonomic neuropathies (Baker et al., 2018b). HRV was
lower for POTS patients than for controls in rest and during
HUT tests (Stewart, 2000; Baker et al., 2018a; Jacob et al., 2019).
Parasympathetic tone seemed to decrease in the upright position
in HUT tests (Baker et al., 2018a). POTS patients showed a
significant increase in LF/HF with tilt compared with the supine
position (Corkal et al., 2014). Resting LF/HF in POTS was
elevated and it increased more with HUT (Furlan et al., 1998).
However, using direct nerve recording, resting sympathetic
activity of POTS patients was found to be low (Jacob et al., 2019)
or normal (Bonyhay and Freeman, 2004; Muenter et al., 2005;
Lambert et al., 2008). A decrease in the cerebral blood flow of
POTS patients in the HUT test was associated with an increase in
the peripheral sympathetic tone (Del Pozzi et al., 2014).
In the present study, our aim was to present and compare
clinical and demographic characteristics of a group of adolescent
POTS patients with a group of adolescent patients without
POTS in Finland. In addition, we aimed to compare HRV and
autonomic functional parameters [blood pressure (BP), HF, LF,
LF/HF], and their temporal changes between the subjects positive
and negative for POTS in different states of HUT tests in the
group level. We hypothesized that HF, ergo parasympathetic
tone, would decrease more in the POTS group in the HUT test
compared with the subjects without POTS.
MATERIALS AND METHODS
We systematically analyzed data obtained from all adolescent
patients (years 9–17), who had been studied for suspected
dysautonomia in Vitalmed Helsinki Sleep Clinic in 2015–
2018. Vitalmed Helsinki Sleep Clinic is a private sleep clinic
where patients from all over Finland – but predominantly
from the Helsinki area – visit either self or insurance paid
or are referred and paid for by their municipal health care.
All the patients in this age group who had been subject
to HUT test were included in the analysis. Thirty-eight
adolescents fulfilled these conditions. All the adolescents tested
had symptoms indicating dysautonomia – e.g., orthostatic
intolerance – for which reason the tests were clinically conducted
originally; thus, there were no healthy controls. In addition, we
analyzed patient files and questionnaires to obtain demographic
and clinical data.
One of the subjects had consumed propranolol 10 mg daily
during the HUT test; thus, the subject was excluded from the
analysis. This left us with 37 subjects. None of the other subjects
used medication that influenced HR or BP before or at the time
of the measurements.
In our analysis, we compared the groups with and without
clinical POTS. We analyzed the raw data of the HUT tests
individually and made group-level comparisons. The subjects
included in the POTS group met the current criteria for
POTS (Sheldon et al., 2015). A neurologist with experience on
dysautonomia confirmed the diagnoses of POTS.
The study was conducted according to the declaration of
Helsinki. Data of all the subjects were anonymized before the
analysis of the data. Institutional review board of Vitalmed
Helsinki Sleep Clinic approved the study. As the study was
based only on documents completed during normally scheduled
outpatient visits and diagnostic procedures, no written informed
consent was required.
Continuous ECG and BP Measurements
All the subjects had undergone an in-laboratory HUT test with
continuous BP and ECG measurement with SOMNOscreen
system (Somnomedics, Randensacker, Germany). The values of
the parameters were exported using the build-in export data
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tool from the SOMNOscreen program. The SOMNOscreen
system included beat-to-beat continuous, non-invasive BP
measurement based on pulse transit time (PTT) from ECG
leads to pulse oximeter at fingertip. PTT method is a validated
and patented non-invasive technique to study ambulatory
BP (Bilo et al., 2015). BP was individually calibrated for
each subject three times in the recumbent position using
a cuff method. ANS activity was analyzed using frequency
domain methods of HRV (HF, LF, LF/HF) equivalent to the
guidelines given by the European Society of Cardiology and
the North American Society of Pacing and Electrophysiology,
but 1–3 min time intervals were used (Camm et al., 1996;
Berntson et al., 1997). Fast Fourier transform was used in
the spectral analysis. The ECG signal was sampled at 256 Hz
and was visually and automatically scanned for artifacts and
non-sinus rhythms. The collected parameters were HR, high-
frequency components of HRV spectra in absolute units (HF,
0.15–0.4 Hz), low-frequency components of HRV spectra in
absolute units (LF, 0.04–0.15 Hz), LF/HF ratio, systolic blood
pressure (SBP), diastolic blood pressure (DBP), and mean
arterial pressure (MAP).
HUT Test
All the tests were performed between 10:00 and 12:00 in a quiet
room. The subjects were asked to rest in recumbent position for
at least 10 min. The preferred active standing HUT method was
used (Chémali and Chelimsky, 2014): the patients were asked to
stand up leaning to a wall at an angle of 70 degrees from the
horizontal. The HUT test lasted for 25 min unless the subject felt
unbearable symptoms or symptoms of presyncope before the end
of the test (9/37 patients had to stop the test before 25 min; none
of their data was excluded from the analysis).
We collected the data of specific parameters – HR, HF, LF,
LF/HF, DPB, SBP, and MAP – during these described time
intervals in the HUT test. Pre-tilt supine: 2 min before upright
position in recumbent position. HUT 1 min: during the first
minute of upright position. HUT 2–4 min: from the second to
fourth minutes of upright position. HUT final: during the last
minute of upright position. Post-tilt supine: from the first to
third minute after returning to the recumbent position. Average
HUT: the average of the parameters during the whole time in the
upright position.
These time intervals were selected for the analysis because
we wanted to analyze the temporal variation of the ANS during
the HUT test. Because the test length was different in some
individuals, we did not use minute-by-minute analysis of the
whole test period. We compared the individual increases and
decreases of HRV, HR, and BP parameters between the groups
of subjects with and without POTS. The patients were classified
in the POTS group if they fulfilled criteria for POTS in the
HUT test (Sheldon et al., 2015), the others were classified in
the non-POTS group.
Subjective Questionnaires
The subjects had completed questionnaires including Epworth
Sleepiness Scale (ESS), Rimon’s Brief Depression Scale (RDS)
(Keltikangas-Jarvinen and Rimon, 1987), World Health
Organization–Five Well-Being Index (WHO-5 Wellbeing
scale) (Topp et al., 2015), and Conners 3AI attention-deficit
hyperactivity disorder (ADHD) screening tool (MHS, 2018).
In addition, the subjects filled Visual Analog Scales for
Quality of Life and General Health, ranging from 0 to
100%, 100% being the best quality and health. Subjects also
filled Basic Nordic Sleep Questionnaire with questions of
daytime tiredness, sleepiness, and constipation (Partinen and
Gislason, 1995). Information about the use of a wheelchair,
stomach pain, and limb pain was obtained from patient
files. Information about confirmed microbial infections
before the starting point of the symptoms were obtained
from patient files. The data about previous vaccinations
were obtained from a questionnaire that all the patients
had filled with their parents. Patients were also asked to
report the date of the Pandemrix vaccination and of the
Cervarix vaccination.
Statistical Analyses
Statistical analyses were performed using Stata 14.2 (StataCorp,
TX, United States). The different variables were tested for
normality using the Shapiro-Wilk test. Group comparisons
between subjects with and without POTS in selected time
intervals of the HUT test were conducted using the two-
sample Wilcoxon rank-sum (Mann–Whitney) test, and p-values
were computed with z scores when the variables were non-
parametrically distributed, and with the independent samples
t test when the parameters were parametrically distributed.
The temporal changes of each dependent variable between
different intervals were conducted using the sign test, as the
distributions were non-parametrical. The results were confirmed
with the dependent-samples t-test. A p < 0.05 was used to
denote significance.
Similarity between the groups of subjects (POTS and non-
POTS) were tested with logistic regression or with Fisher’s exact
test, when appropriate.
RESULTS
Comparison of Demographic and Clinical
Characteristics Between the Groups
Twenty-five (68%) of the tested adolescents fulfilled the
previously described criteria of POTS, and 12 did not. There were
no significant differences in age, sex, or body mass index (BMI)
between the groups with and without POTS. Table 1 shows the
demographic and clinical characteristics and selected symptoms
of the subjects with and without POTS.
There were no significant differences in the number of patients
who had a score of ≥12 in RDS, which refers to at least
moderate depression (Keltikangas-Jarvinen and Rimon, 1987), or
Conners 3AI ADHD screening tool scores between the groups. In
other words, there were no significant differences in depressive
symptoms or ADHD symptoms. The overall quality of life and
perceived general health were low in patients with POTS. There
was a trend to lower subjective experience of general health
in the POTS group, but the difference was not statistically
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TABLE 1 | Clinical characteristics of subjects with and without POTS.
POTS n = 25 Non-POTS n = 12 P-value
Age (years)* 14 (9–17) 11 (9–16) 0.136‡
Female/male 14:11 4:8 0.295†
BMI (kg/m2)* 20.1 (14.7–28.2) 19.5 (14.2–29) 0.682‡
ESS score at least 10** 6/20 (30%) 0/11 (0%) 0.066†
RDS at least 12** 4/20 (20%) 1/12 (8%) 0.623†
WHO-5* 32 (8–96) 52 (16–88) 0.289†
Conners 3AI score at
least 10**
8/19 (42%) 5/12 (42%) 1.000†
Quality of life, Visual
Analog Scale*
47% (0–100%) 60% (8–100%) 0.518‡
General health, Visual
Analog Scale*
32% (0–95%) 60% (25–100%) 0.101‡
Sleepiness for at least
3 days a week**
12/20 (60%) 2/12 (17%) 0.028†
Tiredness for at least
3 days a week**
16/20 (80%) 8/12 (67%) 0.433†
Constipation at least
3 days a week**
2/18 (11%) 2/12 (17%) 1.000†
Abdominal pain** 9/25 (36%) 3/12 (25%) 0.711†
Limb pain** 14/25 (56%) 5/12 (42%) 0.495†
Subject in a
wheelchair**
4/25 (16%) 1/12 (8%) 1.000†
*Values are means with range. **Values are numbers of subjects with percentage.
†P-values were computed with Fisher’s exact test. ‡P-values were computed
with logistic regression. POTS, subjects with postural tachycardia syndrome; non-
POTS, subjects without postural tachycardia syndrome; BMI, body mass index;
ESS, Epworth Sleepiness Scale; RDS, Rimon’s Brief Depression Scale; WHO-
5, World Health Organization–Five Well-Being Index; Conners 3AI, Conners 3AI
attention-deficit hyperactivity disorder screening tool.
significant. Subjects with POTS felt statistically significantly
more often sleepy than subjects without clinical POTS. One
of the patients in the POTS group had narcolepsy type 1.
There were no differences in the occurrence of constipation
or pain between the groups. Four patients in the POTS group
were in a wheelchair because of severe subjective symptoms of
orthostatic intolerance.
Supplementary Table S1 depicts the history of microbial
infections and vaccinations before symptoms. Sixty percent of
POTS patients described symptoms of antecedent infections
before symptoms. None of the described viral or bacterial
infections were significantly more common in the POTS group.
There was a trend to Mycoplasma pneumoniae infections being
more frequent in the POTS group but, owing to small sample size,
the difference was not significant. In both groups, all the patients
had undergone the National Immunization Program (NIP) in
Finland. There were no significant differences in the frequency
of Pandemrix (ASO3 adjuvanted AH1N1 influenza) or Cervarix
[human papillomavirus (HPV)] vaccinations between the groups.
The Cervarix vaccination was obtained between 2013 and 2015
and the Pandemrix vaccination 2009.
HR, HF, LF, LF/HF, and BP in HUT Tests
Table 2 shows the average HR and SBP values in group level in
the selected time intervals during the HUT and the change in HR
from supine to upright (delta HR). Tables 3–5 depict the group
TABLE 2 | Average HR and SBP during the HUT tests.
POTS n = 25 Non-POTS n = 12
Pre-Tilt supine HR* (beats per minute) 74.6 (10.20) 74.08 (11.10)
HUT 1 min HR* (beats per minute) 103.9 (13.15) 99.2 (13.41)
HUT 2–4 min HR* (beats per minute) 100.8 (13.38) 94.3 (11.34)
HUT final HR* (beats per minute) 108.6 (17.77) 95.3 (14.49)
Post-Tilt supine HR* (beats per minute) 74.9 (13.16) 71.1 (8.68)
Maximal heart rate upright* (beats per
minute)
133.8 (12.19) 126.5 (15.10)
Delta HR** (beats per minute) 52 (40–70) 34.75 (29–39)
Pre-Tilt supine SBP* (mmHg) 108.7 (10.62) 103.9 (12.56)
Average HUT SBP* (mmHg) 111.1 (13.42) 105.7 (15.32)
Post-Tilt supine SBP* (mmHg) 111.4 (12.61) 105.5 (16.29)
*Values are means with standard deviation. **Values are means with range. POTS,
subjects with postural tachycardia syndrome; non-POTS, subjects without postural
tachycardia syndrome; HR, heart rate in beats per minute; SBP, systolic blood
pressure in mmHg; Pre-Tilt supine, 2 min before upright position in recumbent
position; HUT 1 min; during the first minute of upright position; HUT 2–4 min, from
the second to fourth minutes of upright position; HUT final, during the last minute
of upright position; Post-Tilt supine, from the first to third minutes after returning
to the recumbent position; Average HUT, the average of the parameters during the
whole time in the upright position.
averages of individual changes of the absolute values of the HRV
parameters between selected time intervals.
In the beginning of the HUT test, the value of HF decreased in
all the subjects in the POTS group and in the non-POTS groups
compared with the value in recumbency. From the beginning of
the upright position in the HUT tests, the value of HF gradually
decreased toward the end of the upright position (p < 0.05)
in both groups compared with the value in recumbency (see
Figure 1). Compared with recumbency, in the first minute of
the HUT test, the decrease in HF was significantly larger in the
POTS group than in the non-POTS group (p = 0.04, z = 2.012).
There was also a similar trend of bigger HF decrease in the POTS
group throughout the whole HUT test, but the difference between
the groups did not reach significance in other time intervals
(data not shown).
The value of LF, at first, slightly increased and then gradually
significantly decreased in the POTS group (p < 0.05), and in the
non-POTS group the value of LF did not significantly increase
in the beginning of the HUT or decrease toward the end (see
Figure 2). In both groups, the value of LH/HF gradually increased
toward the end of the upright position (p < 0.05) (see Figure 3),
and the increase in LF/HF was significantly bigger in the POTS
group in the first to fourth minutes from the beginning of the
HUT test (p = 0.01, z = 2.5), whereas in the other time intervals
there was only a trend of steeper LF/HF increase that did not
reach significance. There were no significant differences between
the values of the absolute change in LF between the groups
(data not shown).
By way of illustration, Supplementary Figures S1, S2 present
the selected parameters of one subject in each group – POTS and
non-POTS – during their HUT tests.
There were no significant differences in the averages of the
absolute values in HRV variables or BP variables (LF, HF, LF/HF,
DBP, SPB, and MAP) between the groups in any of the previously
described time intervals (data not shown). The individual
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TABLE 3 | Temporal changes in HF in head-up tilt tests.
POTS n = 25 P-value Non-POTS n = 12 P-value
Change in HF from Pre-Tilt supine to HUT 1 min 463 (391) to 402 (331) <0.0001 364(216) to 330 (193) 0.0002
Change in HF from Pre-Tilt supine to HUT 2–4 min 463 (391) to 279 (221) <0.0001 364(216) to 248 (135) 0.0032
Change in HF from Pre-Tilt supine to Average HUT 463 (391) to 163 (119) <0.0001 364(216) to 180 (127) 0.0032
Change in HF from Pre-Tilt supine to HUT final 463 (391) to 85 (69) <0.0001 364(216) to 134 (160) 0.0059
Change in HF from HUT 1 min to HUT final 402 (331) to 85 (69) <0.0001 330(193) to 134 (160) 0.0059
Change in HF from HUT final to Post-Tilt supine 85 (69) to 236 (174) <0.0001 134(160) to 299 (145) 0.0059
Values are means of the HRV parameters with standard deviation. P-values were computed with the sign test. POTS, subjects with postural tachycardia syndrome;
non-POTS, subjects without postural tachycardia syndrome; HF, high-frequency components of heart rate variability spectra in ms2; Pre-Tilt supine, 2 min before upright
position in recumbent position; HUT 1 min, during the first minute of upright position; HUT 2–4 min, from the second to fourth minutes of upright position; HUT final, during
the last minute of upright position; Post-Tilt supine, from the first to third minutes after returning to the recumbent position; Average HUT, the average of the parameters
during the whole time in the upright position.
TABLE 4 | Temporal changes in LF in head-up tilt tests.
POTS n = 25 P-value Non-POTS n = 12 P-value
Change in LF from Pre-Tilt supine to HUT 1 min 457 (183) to 465 (178) 0.0013 450 (171) to 464 (166) 0.0730
Change in LF from Pre-Tilt supine to HUT 2–4 min 457 (183) to 431 (159) 0.0539 450 (171) to 420 (136) 0.3872
Change in LF from Pre-Tilt supine to Average HUT 457 (183) to 363 (154) 0.0073 450 (171) to 388 (152) 0.1938
Change in LF from Pre-Tilt supine to HUT final 457 (183) to 306 (183) 0.0073 450 (171) to 379 (190) 0.1133
Change in LF from HUT 1 min to HUT final 465 (178) to 306 (183) 0.0005 464 (166) to 379 (190) 0.1133
Change in LF from HUT final to Post-Tilt supine 306 (183) to 379 (209) 0.0001 379 (190) to 432 (148) 0.1133
Values are means of the HRV parameters with standard deviation. P-values were computed with the sign test; POTS, subjects with postural tachycardia syndrome;
non-POTS, subjects without postural tachycardia syndrome; LF, low-frequency components of heart rate variability spectra in ms2; Pre-Tilt supine, 2 min before upright
position in recumbent position; HUT 1 min, during the first minute of upright position; HUT 2–4 min, from the second to fourth minutes of upright position; HUT final, during
the last minute of upright position; Post-Tilt supine, from the first to third minutes after returning to the recumbent position; Average HUT, the average of the parameters
during the whole time in the upright position.
TABLE 5 | Temporal changes in LF/HF in head-up tilt tests.
POTS n = 25 P-value Non-POTS n = 12 P-value
Change in LF/HF from Pre-Tilt supine to HUT 1 min 13.1 (7.0) to 15.4 (7.8) <0.0001 13.4 (5.2) to 15.5 (5.6) 0.0005
Change in LF/HF from Pre-Tilt supine to HUT 2–4 min 13.1 (7.0) to 21.2 (10.6) <0.0001 13.4 (5.2) to 19 (7.1) 0.0002
Change in LF/HF from Pre-Tilt supine to Average HUT 13.1 (7.0) to 34.4 (15.1) <0.0001 13.4 (5.2) to 28.5 (12.3) 0.0032
Change in LF/HF from Pre-Tilt supine to HUT final 13.1 (7.0) to 44.4 (18.2) <0.0001 13.4 (5.2) to 39.6 (19.8) 0.0059
Change in LF/HF from HUT 1 min to HUT final 15.4 (7.8) to 44.4 (18.2) <0.0001 15.5 (5.6) to 39.6 (19.8) 0.0059
Change in LF/HF from HUT final to Post-Tilt supine 44.4 (18.2) to 21.8 (12.6) <0.0001 39.6 (19.8) to 16.5 (7.7) 0.0020
Values are means of the HRV parameters with standard deviation. P-values were computed with the sign test. POTS, subjects with postural tachycardia syndrome;
non-POTS, subjects without postural tachycardia syndrome; HF, high-frequency components of heart rate variability spectra in ms2; LF,: low-frequency components of
heart rate variability spectra in ms2; Pre-Tilt supine, 2 min before upright position in recumbent position; HUT 1 min, during the first minute of upright position; HUT
2–4 min, from the second to fourth minutes of upright position; HUT final, during the last minute of upright position; Post-Tilt supine, from the first to third minutes after
returning to the recumbent position; Average HUT, the average of the parameters during the whole time in the upright position.
variability between patients in HRV parameters is very high,
especially in the frequency domain (Nunan et al., 2010; Sammito
and Bockelmann, 2016); thus, it is not presumable to have
statistically significant differences in group-level comparisons
in a small group of patients. As described previously, the
comparison of individual changes in the absolute values tells
more. We did a power analysis ex post facto and it turned
out that we would have needed a notably bigger study group
(n = 162 in each group) to reach 0.05 statistical significance with
80% power in absolute difference of Pre-Tilt HF between the
groups, for example.
There was no significant orthostatic hypotension reaction in
any of the subjects (see Table 2).
DISCUSSION
The parasympathetic tone, i.e., HF, decreased in the HUT
test in all tested adolescents, and the magnitude of the
vagal (parasympathetic) attenuation gradually increased during
the whole time upright. At the beginning of HUT, the
parasympathetic tone attenuated significantly more in the POTS
group. LF, in turn, increased significantly only in the POTS
group in the beginning of HUT. Unexpectedly, the LF started
to decrease toward the end of HUT in the POTS group, whereas
this decrease was not seen in the subjects without POTS. LF/HF
increased significantly in both groups in upright position, but the
increase was steeper in the POTS group at the beginning.
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FIGURE 1 | Temporal changes in HF during head-up tilt in subjects with and
without postural tachycardia syndrome. The whiskers are adjacent lines,
boxes are 25th to 75th percentile with median, and the dots are outliers.
POTS, subjects with postural tachycardia syndrome; non-POTS, subjects
without postural tachycardia syndrome; HF, high-frequency components of
heart rate variability spectra in ms2; HUT, head-up tilt; Pre-Tilt supine, 2 min
before upright position in recumbent position; HUT 1 min, during the first
minute of upright position; HUT 2–4 min, from the second to fourth minutes of
upright position; HUT final, during the last minute of upright position; Post-Tilt
supine, from the first to third minutes after returning to the recumbent position.
FIGURE 2 | Temporal changes in LF during head-up tilt in subjects with and
without postural tachycardia syndrome. The whiskers are adjacent lines,
boxes are 25th to 75th percentile with median, and the dots are outliers.
POTS, subjects with postural tachycardia syndrome; non-POTS, subjects
without postural tachycardia syndrome; LF, low-frequency components of
heart rate variability spectra in ms2; HUT, head-up tilt; Pre-Tilt supine, 2 min
before upright position in recumbent position; HUT 1 min, during the first
minute of upright position; HUT 2–4 min, from the second to fourth minutes of
upright position; HUT final, during the last minute of upright position; Post-Tilt
supine, from the first to third minutes after returning to the recumbent position.
FIGURE 3 | Temporal changes in LF/HF during head-up tilt in subjects with
and without postural tachycardia syndrome. The whiskers are adjacent lines,
boxes are 25th to 75th percentile with median, and the dots are outliers.
POTS, subjects with postural tachycardia syndrome; non-POTS, subjects
without postural tachycardia syndrome; HF, high-frequency components of
heart rate variability spectra; LF, low-frequency components of heart rate
variability spectra; LF/HF, LF/HF ratio in ms2; HUT, head-up tilt; Pre-Tilt
supine, 2 min before upright position in recumbent position; HUT 1 min,
during the first minute of upright position; HUT 2–4 min, from the second to
fourth minutes of upright position; HUT final, during the last minute of upright
position; Post-Tilt supine, from the first to third minutes after returning to the
recumbent position.
Our results are in line with earlier studies, where patients with
POTS had a significantly enhanced increase in LF/HF (Furlan
et al., 1998), and a greater decrease in HF in the upright position
period of HUT, compared with controls (Furlan et al., 1998;
Corkal et al., 2014). Contrary to our findings, LF was increased
at 3–5 min of the HUT test compared with recumbency in
one study (Corkal et al., 2014). Previously, the stimulation of
sympathetic tone during HUT, measured by microneurography,
was lower in POTS than in controls, although resting muscle
sympathetic nerve activity in POTS patients was higher than in
controls (Furlan et al., 1998). The significant vagal attenuation
we saw during HUT in both groups was also seen in another
previous study (Baker et al., 2018a). In our study, there were
no significant differences between the absolute sympathetic or
parasympathetic HRV parameters between the groups before,
during, or after HUT. Previously, there have been reports of lower
parasympathetic and sympathetic tone in POTS patients than in
controls before HUT in recumbency, and during the HUT tests
(Stewart, 2000; Baker et al., 2018a). However, in a meta-analysis
there were no significant differences in HF, LF, or LF/HF in
recumbency after HUT in POTS patients compared with controls
(Swai et al., 2019).
Our findings suggest that the central autonomic control might
be impaired in POTS – because POTS patients have intolerable
symptoms standing up – as there was a greater parasympathetic
attenuation compared with the controls in the beginning of
the standing and a greater attenuation in LF compared with
the controls when standing for longer periods of time. This
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attenuation in HF and LF in the upright position could be
associated with the symptoms of orthostatic intolerance in POTS
patients. Much of the evidence in literature indicates that POTS
may be a restricted autonomic neuropathy and our findings may
support this conclusion.
To obtain functional standing hemodynamic, the ANS should
increase sympathetic activity and decrease parasympathetic
activity to increase the systemic vascular resistance and the
cardiac output. For POTS patients, the overemphasized increase
in HR may be a result of decreased sympathetic activity
peripherally. The pathophysiology of POTS includes impaired
sympathetically mediated vasoconstriction, but also excessive
sympathetic drive, volume dysregulation, and deconditioning
(Benarroch, 2012). On the other hand, it is possible that bed
rest or deconditioning, often associated with POTS, in itself
primarily affects the reflex controls of peripheral sympathetic
activity (Benarroch, 2012).
Very high female to male ratios, such as 4:1, have been
described in POTS (Sheldon et al., 2015). In our study, only
a slight majority, 56%, of POTS patients were female, as
in a previously published Finnish incidence study (Skufca
et al., 2017). It could be that POTS is more common
among Finnish males than in other countries for an as
yet unknown reason as is indicated in both studies on the
subject among the Finnish population. To our knowledge, there
is no prevalence studies conducted on the kindred nations
nor in the neighboring countries excluding Denmark. In the
Danish population, the female/male ratio was approximately 3:1
(Brinth et al., 2018).
The autoimmune hypothesis of POTS etiology could be
a link between immune triggers, such as viral and bacterial
infections, or vaccinations, as patients often identify a triggering
factor with the beginning of symptoms. Presence of other
autoimmune disorders has been reported in 20% of POTS
patients (Blitshteyn, 2015).
No associations between POTS and vaccines (Pandemrix,
Cervarix, or NIP of Finland) or previous infections were found in
our group. Of note, exceptionally few had been vaccinated with
Cervarix in the non-POTS group, causing a statistical trend to
higher coverage of the vaccine in the POTS group, though.
A higher proportion of POTS patients reported symptoms
of antecedent infections in our group of adolescents (60%)
than previously described for adults (35%) (Kimpinski et al.,
2012). There was a slight trend to higher prevalence of previous
M. pneumoniae infections in our POTS group than in the
group without POTS, but the association was not significant.
To our knowledge, no sign of this possible association has been
published before.
In our study, the adolescents with POTS were sleepier than
those without POTS, as described also in an earlier study
(Mallien et al., 2014). In our group of POTS subjects, one
adolescent had narcolepsy type 1, which is not a common
comorbidity with POTS (Kim et al., 2018). We did not exclude
any disease groups from our analysis because we wanted to
do a systematic research of all the HUT tests done to the
selected age group. What is more, the overall quality of life
and perceived general health were alarmingly low in subjects
with POTS in our group as previously shown (Benrud-Larson
et al., 2002), and some of our subjects with POTS even used
a wheelchair because of orthostatic intolerance. Still, most of
them did not feel depressed. In a previous study of adolescent
patients, up to 85% reported abdominal pain (Ojha et al.,
2011), whereas the prevalence of abdominal pain was only
36% in our group.
Strengths
Our study is original because, as far as we know, only a few
studies of adolescents with POTS describe detailed demographic
and history data, and HRV in HUT tests have been published.
Limitations
The study sample in this age group was very small, hence large
numerical differences in the parameters did not reach statistical
significance. This probably predisposes to type II errors. Further,
all the subjects in both groups had undergone the tests clinically;
thus, we did not have an asymptomatic control group, and
it might be that the subjects in the non-POTS group could
have other forms of orthostatic intolerance that presents with
sympathetic and vagal disturbances. This, on the other hand,
creates strength to the research setup as the adolescents in both
groups were equally symptomatic and the existence of POTS was
the only thing that separated the groups.
We used the criteria recommended by Sheldon and coworkers
(Sheldon et al., 2015), but even stricter diagnostic criteria for
adolescent POTS have been introduced (Singer et al., 2012).
Blood pressure during HUT was obtained using PTT
estimation. Even though individual calibration reduces the
error associated with PTT, changes in autonomic state can
affect the blood pressure values as much as 10 mmHg
(Sklarsky et al., 2019).
All the results were controlled by sex and BMI, but we did
not obtain information about the subjects’ physical activity nor
socioeconomic status. This information would have been of value
in finding possible confounding factors.
CONCLUSION
Our findings indicate that parasympathetic tone attenuated in
both groups in HUT, and the attenuation was bigger in POTS.
In the beginning of HUT, LF increased more in POTS, but
in the end of the upright position period, an attenuation in
LF was seen in the POTS group. These results imply that the
autonomic response to the upright position might be impaired
in POTS correlating with orthostatic intolerance. There were no
associations of previous infections or vaccinations with POTS.
Subjects with POTS were significantly sleepier than subjects
without POTS, and their quality of life was low.
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FIGURE S1 | Head-up tilt of a subject with postural tachycardia syndrome.
Signals from above: HR, LF, HF, and LF/HF. HR, heart rate; HF, high-frequency
components of heart rate variability spectra; LF, low-frequency components of
heart rate variability spectra. The time interval between two vertical lines is 1 min.
FIGURE S2 | Head-up tilt of a subject without postural tachycardia syndrome.
Signals from above: HR, LF, HF, and LF/HF. HR, heart rate; HF, high-frequency
components of heart rate variability spectra; LF, low-frequency components of
heart rate variability spectra. The time interval between two vertical lines is 1 min.
The red colored line is a 90 beats per minute indicator line.
TABLE S1 | History of confirmed microbial infections and vaccinations prior to
symptoms.
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